selected publications
-
academic article
- Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument.. Arthritis and rheumatism. 57:1280-6. 2007
- Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 16:1083-92. 2007
- Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument. Arthritis & Rheumatism-arthritis Care & Research. 2007
- Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis. Quality of Life Research. 2007
- Assessment of SF-6D, a preference measure, in systemic sclerosis. Arthritis & Rheumatism-arthritis Care & Research. 2006
- Development of the scleroderma gastrointestinal tract 1.0 (SSc-GIT1.0) quality of life instrument - Preliminary report. Arthritis & Rheumatism-arthritis Care & Research. 2006
- Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Annals of the Rheumatic Diseases. 2006
- Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.. The Journal of rheumatology. 32:832-40. 2005
- Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. The Journal of Rheumatology. 2005
- Responsiveness of the health related quality of life (HRQL)instruments (SF-36 and HAQ-DI) in a systemic sclerosis (SSc) clinical trial. Arthritis & Rheumatism-arthritis Care & Research. 2003